Dublin, June 25, 2020 (GLOBE NEWSWIRE) -- The "Global Breast Cancer Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering.

This report provides the most up-to-date information on key pipeline products in the global Breast Cancer market. It covers emerging therapies for Breast Cancer in active clinical development stages including early and late-stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Breast Cancer pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Breast Cancer pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Breast Cancer pipeline products by company.

Short-term Launch Highlights:
Find out which Breast Cancer pipeline products will be launched in the US and beyond to 2025.

Key Topics Covered:

1. Breast Cancer Pipeline by Stages
2. Breast Cancer Phase 3 Clinical Trial Insights
3. Breast Cancer Phase 2 Clinical Trial Insights
4. Breast Cancer Phase 1 Clinical Trial Insights
5. Breast Cancer Preclinical Research Insights
6. Breast Cancer Discovery Stage Insights
7. Appendix
8. Research Methodology

List of Tables
Table 1: Breast Cancer Phase 3 Clinical Trials, 2020
Table 2: Breast Cancer Phase 2 Clinical Trials, 2020
Table 3: Breast Cancer Phase 1 Clinical Trials, 2020
Table 4: Breast Cancer Preclinical Research, 2020
Table 5: Breast Cancer Discovery Stage, 2020

List of Figures
Figure 1: Breast Cancer Pipeline Molecules by Clinical Trials Stage, 2020
Figure 2: Breast Cancer Phase 3 Clinical Trial Highlights, 2020
Figure 3: Breast Cancer Phase 2 Clinical Trial Highlights, 2020
Figure 4: Breast Cancer Phase 1 Clinical Trial Highlights, 2020
Figure 5: Breast Cancer Preclinical Research Highlights, 2020
Figure 6: Breast Cancer Discovery Stage Highlights, 2020

For more information about this report visit https://www.researchandmarkets.com/r/nljxkf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900